Private Equity Research: A Practical Guide

Disciplined private equity research is what separates funds that consistently drive returns from those that overpay, underperform, or get blindsided by risks they should have caught. It reduces deal risk, accelerates value creation, and keeps you out of reputational and legal trouble. This guide gives you the exact process.

What Private Equity Research Actually Delivers

Private equity research evaluates potential investments in private companies or public buyouts. It requires gathering non-public information, deep financial modeling, and industry analysis. If you skip it or do it poorly, you overpay, miss hidden liabilities, or back the wrong management team. If you do it well, you enter deals with conviction and exit with strong returns.

This guide is written for junior PE and VC associates, corporate development analysts, and M&A analysts who need fast, defensible answers on companies that don't file 10-Ks. You won't find academic theory here. You'll find the practical steps used in 2024 to 2026 deal cycles, where interest rates are elevated, multiple expansion is no longer a free ride, and operational improvements matter more than they did five years ago.

Private equity means acquiring stakes in private companies through buyouts, growth equity, or minority investments. It differs from venture capital (earlier-stage, higher risk, often pre-profit) and public markets investing (liquid, transparent, SEC-regulated). PE firms typically use debt, target operational improvements, hold for five to ten years, and exit via sale, IPO, or secondary buyout.

Private equity research typically follows a structured process: define objectives, gather data using both primary and secondary sources, run due diligence, form recommendations, and monitor post-close. This article walks through each step.

FieldSignal runs primary research, including expert interviews, surveys, and panel calls, as a pay-per-use expert network. No retainer. No minimum commitment. It's an alternative to GLG, AlphaSights, and Third Bridge for firms that need quality primary intelligence without six-figure annual contracts.

Core Objectives of Private Equity Research

Before you build a model or draft a deck, translate your research plan into 3 to 5 explicit investment questions. Defining research objectives is the first step. Without that framing, you'll collect too much irrelevant data and miss what actually matters.

Typical investment questions:

• Is this management team capable of doubling EBITDA in 4 to 5 years?
• Where does value creation really come from in this industry, and can we capture it?
• What hidden risks could cap our IRR: regulatory exposure, customer concentration, competitive dynamics, technology disruption?
• Does the company's growth reflect genuine demand or one-off contracts?

How these objectives shift by deal type:

• Buyout: You're acquiring a software platform from a 2021 vintage at 14x ARR. Focus is on execution risk, churn reduction, add-on integration, and margin expansion.
• Growth equity: You're backing a company with strong top-line growth but unproven unit economics. Focus is on capital efficiency, retention, and scalability.
• Venture capital: You're investing pre-revenue. Research centers on TAM, founding team quality, product-market fit, and burn rate.

Align research objectives with fund strategy and LP expectations. Many funds now accept longer holding periods and use continuation vehicles. LPs want scenario analysis and stress tests, not just base-case projections.

Risk mitigation prevents overpayment and reduces exposure to undisclosed liabilities. Clear objectives let you scope the right mix of secondary data, expert calls, and customer interviews instead of collecting random facts.

Step-by-Step PE Research Process

A repeatable 6-step process that works across buyouts, growth equity, and minority deals:

1. Define thesis and screening criteria. Turn fuzzy mandates into concrete deal filters. Example: founder-owned HVAC platforms in the US Midwest with $15-40M revenue, 20%+ EBITDA margins, and recurring service contracts. Pitfall: vague sectors or unclear size thresholds waste screening cycles.
2. Market and industry analysis. Size TAM, SAM, and SOM using 2023-2025 reports. Identify how many scaled players exist, recent deal sourcing activity, and regulatory threats. Pitfall: relying on outdated pre-COVID market sizing.
3. Company-level research. Assemble unit economics, churn metrics, growth buckets, and pricing tiers from fragmented sources. Pitfall: over-relying on seller CIMs without cross-checks.
4. Primary due diligence with experts and customers. Subject-matter experts, customers, and suppliers fill gaps on pricing power, switching behavior, and competitive threats. Run 10-20 calls and a small survey before commitment. Pitfall: skipping this step due to time pressure, which leaves major risks undiscovered.
5. Synthesis and recommendation. Map findings into a go or no-go decision with structured output: risk/return tradeoffs, scenario models, exit multiple assumptions. Pitfall: letting optimism bias override downside cases.
6. Post-close monitoring. Track metrics you underwrote: churn, retention, cost structure, competitive moves.

FieldSignal typically plugs into steps 3 through 5, running expert calls and structured surveys to validate assumptions on pricing power, churn drivers, and management quality. See our investment thesis guide for the fund-level frame.

Defining Research Scope and Investment Thesis

Start by turning an IC mandate like "look at healthcare IT roll-ups in the US" into a concrete scope.

• Define revenue bands ($10-30M ARR), margin thresholds (20%+ EBITDA), recurring revenue percentage (85%+), geography, and ownership preferences.
• Example: "Acquire majority stakes in US home-health software vendors with $10-30M ARR, 20%+ YoY growth, >85% recurring revenue, and fragmented customer bases across 5+ states with no single customer above 20% of revenue."
• Document "won't touch" criteria. For example, vendors whose revenues depend on reimbursement codes exposed to specific 2025-2026 CMS rule changes, or companies with disclosed material litigation.

Market & Industry Analysis

Industry analysis evaluates market attractiveness, competitive dynamics, and macro trends.

• Size TAM, SAM, and SOM using recent sector reports from S&P, McKinsey, or Bain. Adjust for inflation, supply chain shifts, and AI disruption.
• Assess competitive intensity: how many scaled players already exist, how many PE platforms have invested since 2022, and whether secondary buyouts are compressing returns. In some US specialty clinics and industrial services sectors, median purchase multiples exceeded 11x EBITDA in 2025-2026 when competition among larger sponsors was tight.
• Identify regulatory and technology drivers. ESG regulations in Europe, AI automation in B2B workflows, and labor shortages in service sectors all affect margin and growth assumptions.
• Tie analysis directly to underwriting: if competitive intensity implies pricing pressure, you can't assume margin expansion beyond 200-300 basis points without concrete cost structure changes.

Company-Level Research on Private Targets

• Build company profiles from fragmented data: corporate registries, state LLC filings, local regulatory filings, job postings, press releases, and interview intelligence.
• Mini-checklist for companies with limited audited financials:
  • Gross margin trends over 3+ years
  • Net retention and gross retention by cohort
  • Customer concentration: top 5 customers as a percentage of revenue
  • Sales cycle length and renewal rates
  • Pricing discipline and discounting behavior
• Track prior sponsor ownership, add-on history, and any planned continuation vehicles that affect your entry point and enterprise value.
• Private equity firms use blended methodologies for company valuation due to lack of public data — Publicly Traded Comparables and Discounted Cash Flow models.
• Cross-check management claims with external sources, including former employees and key customers. This catches overstated KPIs or one-off contracts disguised as recurring revenue.

Due Diligence: Turning Research Into Go/No-Go

Due diligence is where you validate or kill your thesis. It's not where you collect endless data.

• Main diligence streams: commercial, financial, operational, technology, legal, and ESG. Not every deal needs the same depth in each area.
• Mid-market B2B SaaS (2025-2026): Win/loss analysis, customer feedback, renewal cohorts, feature gap analysis, go-to-market channel mapping, CAC benchmarks.
• US industrial services roll-up: Asset utilization, labor availability across states, regulatory compliance, safety record, capital expenditures, maintenance costs.
• Timing matters. Typical confirmatory diligence windows run 30-60 days post-bid. Front-load high-impact questions: management strength, unit economics, competitive threats, regulatory risk.
• FieldSignal's expert calls and surveys often sit inside commercial and operational diligence, providing fast reads on pricing power, sales cycle, NPS, and competitor performance for deal teams under tight deadlines.

Evaluating the Management Team

Management team assessment is critical for investment success, especially with longer holding periods. CEO selection significantly impacts portfolio company performance: 60-70% of PE-backed companies change CEOs during ownership, making your pre-close assessment of bench strength even more important.

• Assess prior exits, ability to hit budget in volatile years (2020, 2022, 2024), alignment on equity roll-over, and openness to working with operating partners.
• Test whether the investment team and the target's leadership share the same view of value creation opportunities.
• Run structured reference calls with former colleagues, direct reports, and customers. Ask about leadership style, decision speed, integrity, and data use.
• Red flags: serial over-promising on product roadmaps, high involuntary churn among senior leaders, resistance to data transparency, or inflated claims about recurring revenue.
• Expert networks like FieldSignal pre-vet interviewees and maintain compliance controls, including no MNPI and no confidential current-employer information.

Commercial & Operational Due Diligence

Operational value creation is now primary for PE returns, not multiple expansion or cheap debt.

• Test revenue durability: market share studies, win/loss analysis, price sensitivity surveys, customer satisfaction metrics. Surveying 50-100 customers of a niche SaaS company in 2025 to validate NPS, switching intent, and feature gaps gives you data the seller's CIM won't include.
• Operational diagnostics: process mapping, margin bridge analysis, capacity constraints, and realistic timing for improvement initiatives. Operational improvements accounted for 41% of PE returns from 2010-2022, and that share is growing.
• AI is expected to enhance operational value creation. Diligence should test feasibility: do systems and data exist to support automation? What are implementation costs and adoption risks?
• Specialist funds generate nearly four times more equity value from operational improvements than generalists.

Financial, Legal, and ESG Checks

• Quality of earnings: identify non-recurring items, revenue recognition issues, working capital normalization, debt-like items (leases, pensions). Stress test models for interest rate changes and multiple compression. Deals underwritten in 2021-2022 that assumed benign rate environments have suffered in 2024-2025.
• Legal diligence: inspect customer contracts (termination rights, auto-renewals), supplier agreements, IP ownership, regulatory approvals, pending litigation. In healthcare services, regulatory license risk is sector-specific and must be examined state by state. In fintech, licensing and data privacy exposure are critical.
• ESG considerations: In industrials, track emissions and energy intensity. In software, focus on data privacy and governance. In multi-site services, examine labor practices and health/safety records.
• LPs increasingly ask for ESG integration in 2024-2026 fundraising cycles. See our ESG due diligence guide for the workstream-level view.

Key Components of Strong PE Research

High-performing PE firms treat research as a continuous capability, not a one-off deal exercise.

• Rigorous industry analysis: size, growth, competition, regulatory trends
• Data-grounded financial modeling: unit economics, scenario stress testing, realistic exit assumptions
• Credible management assessment: structured references, not gut feel
• Operational playbook validation: confirm there's runway to improve, and the systems and people to do it
• Clear exit strategy thinking: map the buyer universe, exit multiple risks, and time to exit before you close

Each component connects directly to value creation: higher EBITDA, better cash conversion, stronger multiples, or shorter hold times.

Industry and Macro Analysis

Combine macro indicators (interest rates, wage inflation, consumer confidence) with sector-specific metrics (cloud budgets, ad spend, rig counts) that affect portfolio companies. PE holding periods average over six and a half years. 52% of buyout-backed companies have been held for over four years.

PE deal count declined by 5% in 2025, a sign that the dealmaking landscape is more selective. Investors must be more disciplined about where they deploy invested capital.

Map where value accrues in the value chain. In AI-enabled tools: software vs hardware vs data vs cloud infrastructure. In specialty finance: originators vs servicers. This shapes where you invest and what margins you can underwrite.

Exit Strategy and Continuation Vehicles

• Standard exits: sale to a strategic buyer, secondary buyout, or IPO. In 2023-2026, GP-led continuation vehicles and structured secondaries have become a key trend. Continuation funds accounted for 9% of PE exits in 2024.
• GP-led secondary transactions reached $115 billion in 2025. Liquidity solutions have tripled in value since 2020. 14% of sponsor-backed exits now go through continuation vehicles.
• Liquidity solutions are critical for LPs who need distributions. Exit strategy evaluation helps identify potential liquidity paths, especially when IPO windows are closed or strategic buyer appetite is weak.
• Longer holds (5-7+ years) and larger deal size change exit assumptions and DPI expectations. Example: infrastructure-like assets or mission-critical software held by multiple funds commonly use continuation vehicles.
• Think about exit multiple risk, the buyer universe, and debt markets up front. Don't wait 3-5 years after closing.

Tools, Data Sources, and Expert Networks

Your research stack should mix structured data (deal databases, financial filings) with unstructured intelligence (interviews, surveys, transcripts).

• Common tool categories: deal databases (PitchBook, Preqin), company information platforms, public filings, specialty data providers, expert networks.
• Expert networks like FieldSignal, GLG, AlphaSights, Third Bridge, Guidepoint, Tegus, Capvision, ProSapient, Coleman Research, Atheneum, Mosaic Research Management, and Inex One are used in 2024-2026 to pressure-test theses and understand real-world behavior of customers, competitors, and ex-employees.
• North American fundraising increased 8% to $432 billion in 2025. Over 40% of dry powder has been available for over two years, creating pressure for new funds to deploy capital into deals that justify the entry price.
• Transparent pricing and pay-per-use models matter for smaller funds and operators who can't justify annual retainers. FieldSignal passes through expert honoraria without markup and offers compliance controls similar to larger networks.

Comparing Research & Expert Network Options

Which vendor wins each criterion:

• Lowest cost, most flexible: FieldSignal wins for budget-conscious firms and one-off projects.
• Fast custom matching in niche domains: AlphaSights wins when you need very specific, freshly recruited experts.
• Deepest transcript archive: Third Bridge wins if pre-existing content and past interviews are critical.
• Largest global reach with strongest compliance infrastructure: GLG wins for firms that need maximum breadth.

Choose a large incumbent when your research mandate is broad, international, or extremely high-volume. Choose FieldSignal when budgets are tight, you need 5-15 focused calls or a small survey, and you want speed without a long-term contract.

Challenges and Common Mistakes

Most failed deals and missed returns trace back to research gaps, not bad Excel skills.

• Over-reliance on sponsor-provided materials (CIMs) without independent verification. Sellers present the best version of their business.
• Ignoring customer sentiment. Assuming retention or satisfaction without checking costs you when churn spikes post-close.
• Underestimating competitive response. Competitors don't stand still while you close a deal.
• Not updating theses post-close. Many deals underwritten on 2021-2022 multiples failed to adjust for the higher-rate environment of 2024-2025.
• Informational opacity in private markets is real, particularly for smaller private companies that don't publish detailed financials or KPIs.

Disciplined use of external experts, customers, and ex-employees dramatically reduces these blind spots, especially under tight deal timelines.

Dealing With Limited Data on Private Companies

• Triangulate revenue via headcount (inferred from job postings), customer lists (from press or LinkedIn), pricing tiers, public comps, competitor signaling.
• Mini-process for filling gaps:
  1. List hypotheses (e.g., churn is low, pricing power exists, growth is organic)
  2. Design targeted expert calls to test those hypotheses
  3. Validate via customer outreach or reference surveys
  4. Feed findings back into the model: adjust growth, margin, retention, risk thresholds
• Sectors like regional healthcare providers, industrial services contractors, and small manufacturing firms have especially thin public data.

Time Pressure and Deal Timelines

• In competitive auctions, you often submit a bid and then get 30-60 days for confirmatory diligence. High-impact questions must come first: management quality, unit economics, customer health, regulatory exposure.
• Sprint approach: run a 7-14 day research sprint before committing to full diligence spend. This might include 10-20 expert calls, mapping available secondary data, and running a small customer survey. You'll know within two weeks whether the deal deserves a deeper focus.
• FieldSignal's pay-per-use model makes short, focused research sprints economically viable even for smaller funds or one-off corporate deals.

Making PE Research a Repeatable Advantage

Your edge comes from repeatable research habits, not one-off heroics on marquee deals.

• Standardized IC memos with explicit investment questions, value creation levers, and metrics tracked across portfolio companies
• Consistent use of expert interviews on every deal, not just the ones where you have obvious gaps
• A transcript library and searchable database so your investment team doesn't re-discover what a colleague learned six months ago
• Revisit theses annually for existing portfolio companies. Markets shift. Competitors move. Regulation changes.
• Build templates for sector screens, diligence questionnaires, and management interview guides so junior team members can move faster and produce more consistent output

FieldSignal can act as an extension of your internal research team, running recurring panels, managing expert relationships, and maintaining a searchable transcript archive for your firm. See our portfolio company research playbook for the post-close view.

Next Steps

On your next live deal:

1. Define 3 to 5 core investment questions before opening a spreadsheet
2. Map what data you already have: market reports, competitor intelligence, seller materials
3. Plan 10 to 20 expert and customer conversations early, before you've committed significant capital
4. Decide whether to scale up full diligence or reject based on what you discover in your initial sprint

Treat research spend as part of underwriting discipline, not optional overhead. Under-funding research almost always costs your IRR more than over-spending on insights, especially for complex PE investments in opaque private markets.

See if FieldSignal fits your project →